Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dose-rate as a critical aspect of cellular response to gamma-radiation

Jiřina Vávrová, Martina Řezáčová, Zuzana Šinkorová, Aleš Tichý

. 2018 ; 87 (3) : 119-125.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19009023

Ionizing radiation (IR) induces various types of damage in the cellular DNA, of which the most deleterious are double strand breaks. Double strand breaks lead to activation of signaling cascade aiming to repair the damage or to transiently or permanently arrest cell cycle, and/or induce cell death. In the case of high doses of ionizing radiation with a high dose-rate (0.5-1 Gy / min) where the cell repair capacity is insufficient, cell death often occurs in response to double-strand breaks. The response to the radiation exposure depends on many factors such as the cell type, its proliferation activity, and p53 status. In tumor cells, cell death is associated primarily with apoptosis or mitotic catastrophe. In normal fibroblasts, cells accumulate in the G1-phase of the cell cycle and so-called premature senescence occurs after irradiation. In cells with functional p53 protein an increase in the p21 protein (cell division inhibitor) and accumulation of the cells in the G1-phase occurs. In the case of very low-dose rate (LDR), this accumulation is transient; after DNA damage repair, the cells continue to divide. Upon irradiation with higher doses at a LDR, accumulation in the G1-phase is irreversible; p16 protein is upregulated and the status of premature senescence is induced. The same dose of radiation administered at LDRs results in more senescence than after an acute exposure. In the case of the use of IR for the eradication of tumor cells, the status of these cells is important in terms of p53 and proliferation. About fifty percent of tumor cells do not possess p53 protein or are mutant, and after irradiation they accumulate in the G2-phase and repair the IR-induced damage (e.g. HL-60 cells). In HL-60 cells (p53-/- human promyelocytic leukemia), G2-phase accumulation occurs during irradiation with low dose rate, and their radioresistance increases if the cells are irradiated in the G2-phase. When the dose-rate is very low, the cells enter the mitotic cycle during irradiation, and because cels in mitosis are highly radiosensitive, apoptosis is induced and thus their radiosensitivity increases as well.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19009023
003      
CZ-PrNML
005      
20190718132246.0
007      
ta
008      
190311s2018 xr d f 000 0|eng||
009      
AR
024    0_
$a 10.31482/mmsl.2018.016 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Vávrová, Jiřina, $d 1946- $7 xx0004363 $u Department of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence, Czech Republic
245    10
$a Dose-rate as a critical aspect of cellular response to gamma-radiation / $c Jiřina Vávrová, Martina Řezáčová, Zuzana Šinkorová, Aleš Tichý
504    __
$a Literatura
520    9_
$a Ionizing radiation (IR) induces various types of damage in the cellular DNA, of which the most deleterious are double strand breaks. Double strand breaks lead to activation of signaling cascade aiming to repair the damage or to transiently or permanently arrest cell cycle, and/or induce cell death. In the case of high doses of ionizing radiation with a high dose-rate (0.5-1 Gy / min) where the cell repair capacity is insufficient, cell death often occurs in response to double-strand breaks. The response to the radiation exposure depends on many factors such as the cell type, its proliferation activity, and p53 status. In tumor cells, cell death is associated primarily with apoptosis or mitotic catastrophe. In normal fibroblasts, cells accumulate in the G1-phase of the cell cycle and so-called premature senescence occurs after irradiation. In cells with functional p53 protein an increase in the p21 protein (cell division inhibitor) and accumulation of the cells in the G1-phase occurs. In the case of very low-dose rate (LDR), this accumulation is transient; after DNA damage repair, the cells continue to divide. Upon irradiation with higher doses at a LDR, accumulation in the G1-phase is irreversible; p16 protein is upregulated and the status of premature senescence is induced. The same dose of radiation administered at LDRs results in more senescence than after an acute exposure. In the case of the use of IR for the eradication of tumor cells, the status of these cells is important in terms of p53 and proliferation. About fifty percent of tumor cells do not possess p53 protein or are mutant, and after irradiation they accumulate in the G2-phase and repair the IR-induced damage (e.g. HL-60 cells). In HL-60 cells (p53-/- human promyelocytic leukemia), G2-phase accumulation occurs during irradiation with low dose rate, and their radioresistance increases if the cells are irradiated in the G2-phase. When the dose-rate is very low, the cells enter the mitotic cycle during irradiation, and because cels in mitosis are highly radiosensitive, apoptosis is induced and thus their radiosensitivity increases as well.
650    _2
$a ionizující záření $7 D011839
650    _2
$a apoptóza $7 D017209
650    _2
$a buněčná smrt $7 D016923
650    _2
$a vztah dávky záření a odpovědi $7 D004307
650    _2
$a stárnutí buněk $7 D016922
650    _2
$a lidé $7 D006801
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Řezáčová, Martina, $d 1972- $7 nlk20020124956 $u Institute of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic
700    1_
$a Šinkorová, Zuzana, $d 1963- $7 xx0106471 $u Department of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence, Czech Republic
700    1_
$a Tichý, Aleš, $d 1980- $7 xx0135624 $u Department of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence, Czech Republic; Biomedical Research Centre, University Hospital, Hradec Králové, Czech Republic
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 87, č. 3 (2018), s. 119-125 $w MED00011116
856    41
$u http://www.mmsl.cz/archive $y domovská stránka časopisu
910    __
$a ABA008 $b A 3 $c 1073 $y 4 $z 0
990    __
$a 20190310091951 $b ABA008
991    __
$a 20190718132458 $b ABA008
999    __
$a ok $b bmc $g 1383664 $s 1047284
BAS    __
$a 3
BMC    __
$a 2018 $b 87 $c 3 $d 119-125 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK182 $d 20190718 $a NLK 2019-16/vt

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...